Drug · DIN 02508486
TIROCAP
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since March 28, 2024.
- Drug Identification Number (DIN)
- 02508486
- Company (DIN owner)
- Ibsa Institut Biochimique SaPazzallo, --, Switzerland
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Levothyroxine sodium H03AA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVOTHYROXINE SODIUM | 13 MCG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 21, 2021: NOC 26112Supplement to a New Drug Submission (SNDS) · Product name change
- November 25, 2020: NOC 24674New Drug Submission (NDS)
Other DINs named TIROCAP
- DIN 02508494 · Cancelled Pre Market
- DIN 02508508 · Cancelled Pre Market
- DIN 02508516 · Cancelled Pre Market
- DIN 02508524 · Cancelled Pre Market
- DIN 02508532 · Cancelled Pre Market
- DIN 02508540 · Cancelled Pre Market
- DIN 02508559 · Cancelled Pre Market
- DIN 02508567 · Cancelled Pre Market
- DIN 02508575 · Cancelled Pre Market
- DIN 02508583 · Cancelled Pre Market
- DIN 02508591 · Cancelled Pre Market